UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device

Journal of clinical sleep medicine, 2007-06, Vol.3 (4), p.387-392

2007

Volltextzugriff (PDF)

Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus

Endocrine practice, 2007-07, Vol.13 (4), p.355-362

2007

Volltextzugriff (PDF)

Therapeutic options in the treatment of insomnia

The journal of clinical psychiatry, 2005, Vol.66 Suppl 9, p.18

Erman, Milton K

2005

Volltextzugriff (PDF)

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: A 12-week, open-label study

Chest, 2003-12, Vol.124 (6), p.2192-2199

2003

Volltextzugriff (PDF)

Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder

Journal of occupational and environmental medicine, 2011-12, Vol.53 (12), p.1460-1465

2011

Volltextzugriff (PDF)

Ask the Expert: Disorders of Sleep

Focus (American Psychiatric Publishing), 2014-01, Vol.12 (1), p.54-55

Erman, Milton K.

2014

Volltextzugriff (PDF)

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia

Journal of clinical sleep medicine, 2008-06, Vol.4 (3), p.229-234

2008

Volltextzugriff (PDF)

New perspectives in the diagnosis and management of insomnia. Introduction

CNS spectrums, 2008-12, Vol.13 (12 Suppl 17), p.3

Erman, Milton K

2008

Volltextzugriff (PDF)

The effect of armodafinil on patient-reported functioning and quality of life in patients with excessive sleepiness associated with shift work disorder: a randomized, double-blind, placebo-controlled trial

Primary care companion for CNS disorders, 2012, Vol.14 (4)

2012

Volltextzugriff (PDF)

Evaluation of the safety of modafinil for treatment of excessive sleepiness

Journal of clinical sleep medicine, 2007-10, Vol.3 (6), p.595-602

2007

Volltextzugriff (PDF)

Insomnia etiology and comorbidity

CNS spectrums, 2008-12, Vol.13 (12 Suppl 17), p.4-6

Erman, Milton K

2008

Volltextzugriff (PDF)

APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia

Sleep (New York, N.Y.), 2008-12, Vol.31 (12), p.1663-1671

2008

Volltextzugriff (PDF)

Selected Sleep Disorders: Restless Legs Syndrome and Periodic Limb Movement Disorder, Sleep Apnea Syndrome, and Narcolepsy

The Psychiatric clinics of North America, 2006-12, Vol.29 (4), p.947-967

Erman, Milton K.

2006

Volltextzugriff (PDF)

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder

Biological psychiatry (1969), 1998-07, Vol.44 (1), p.3-14

1998

Volltextzugriff (PDF)

Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate

Sleep medicine, 2017-10, Vol.38, p.92-95

2017

Volltextzugriff (PDF)

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial

American journal of respiratory and critical care medicine, 2019-06, Vol.199 (11), p.1421-1431

2019

Volltextzugriff (PDF)

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial

The journal of clinical psychiatry, 1997-05, Vol.58 (5), p.185-192

1997

Volltextzugriff (PDF)

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study

Sleep (New York, N.Y.), 2008-01, Vol.31 (1), p.79-90

2008

Volltextzugriff (PDF)

An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia

Sleep medicine, 2006, Vol.7 (1), p.17-24

2006

Volltextzugriff (PDF)

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia

Journal of clinical sleep medicine, 2007-08, Vol.3 (5), p.495-504

2007

Volltextzugriff (PDF)

Sleep architecture and its relationship to insomnia

The journal of clinical psychiatry, 2001, Vol.62 Suppl 10, p.9

Erman, M K

2001

Volltextzugriff (PDF)

Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia

Current medical research and opinion, 2005-02, Vol.21 (2), p.223-229

2005

Volltextzugriff (PDF)

SY5.1 Pharmacological Treatment

Clinical neurophysiology, 2009, Vol.120, p.S7-S8

Erman, Milton Karl

2009

Volltextzugriff (PDF)

Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia

Current medical research and opinion, 2004-04, Vol.20 (4), p.441-449

2004

Volltextzugriff (PDF)

A consensus definition of cataplexy in mouse models of narcolepsy

Sleep, 2009-01, Vol.32 (1), p.111-116

2009

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

Humans
(49)
Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Male
(36)
Adult
(34)
Female
(34)
Middle Aged
(29)
Neurosciences & Neurology
(25)
Clinical Neurology
(24)
Biological And Medical Sciences
(21)
Medical Sciences
(19)
Aged
(18)
Double-Blind Method
(18)
Sleep Initiation And Maintenance Disorders - Drug Therapy
(16)
Neurosciences
(14)
Polysomnography
(14)
Psychiatry
(12)
Insomnia
(11)
Psychology. Psychoanalysis. Psychiatry
(10)
Neurology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device

Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus

Therapeutic options in the treatment of insomnia

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: A 12-week, open-label study

Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder

Ask the Expert: Disorders of Sleep

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia

New perspectives in the diagnosis and management of insomnia. Introduction

The effect of armodafinil on patient-reported functioning and quality of life in patients with excessive sleepiness associated with shift work disorder: a randomized, double-blind, placebo-controlled trial

Evaluation of the safety of modafinil for treatment of excessive sleepiness

Insomnia etiology and comorbidity

APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia

Selected Sleep Disorders: Restless Legs Syndrome and Periodic Limb Movement Disorder, Sleep Apnea Syndrome, and Narcolepsy

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder

Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study

An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia

Sleep architecture and its relationship to insomnia

Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia

SY5.1 Pharmacological Treatment

Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia

A consensus definition of cataplexy in mouse models of narcolepsy

Suchergebnisse filtern